Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 7, 2006
Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma
J Watanabe, K Watanabe, T Jobo, et al.
European Journal of Gynaecological Oncology
|
March 23, 2006
Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose
Y Niibe, K Hayakawa, T Kanai, et al.
Jinrui Idengaku Zasshi. the Japanese Journal of Human Genetics
|
September 1, 1978
A cytogenetic survey of consecutive liveborn infants-incidence and type of chromosome abnormalities
T Maeda, M Ohno, M Takada, et al.
Journal of Cancer Research and Clinical Oncology
|
December 23, 2003
PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus
F Kimura, J Watanabe, H Hata, et al.
European Journal of Gynaecological Oncology
|
March 23, 2006
C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix
M Ohwada, T Wada, Y Saga, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 13, 2005
Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases
S Tsunoda, T Jobo, M Arai, et al.
European Journal of Gynaecological Oncology
|
March 23, 2006
Medroxyprogesterone acetate stimulates cdk inhibitors, p21 and p27, in endometrial carcinoma cells transfected with progesterone receptor-B cDNA
M Kawaguchi, J Watanabe, M Hamano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2010
Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)
H Nomura, D Aoki, F Takahashi, et al.
British Journal of Cancer
|
June 27, 2002
Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters
J Watanabe, H Sato, T Kanai, et al.
European Journal of Gynaecological Oncology
|
November 11, 2010
Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501)
Y Niibe, J Watanabe, S Tsunoda, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 7, 2006
Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma
J Watanabe, K Watanabe, T Jobo, et al.
European Journal of Gynaecological Oncology
|
March 23, 2006
Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose
Y Niibe, K Hayakawa, T Kanai, et al.
Jinrui Idengaku Zasshi. the Japanese Journal of Human Genetics
|
September 1, 1978
A cytogenetic survey of consecutive liveborn infants-incidence and type of chromosome abnormalities
T Maeda, M Ohno, M Takada, et al.
Journal of Cancer Research and Clinical Oncology
|
December 23, 2003
PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus
F Kimura, J Watanabe, H Hata, et al.
European Journal of Gynaecological Oncology
|
March 23, 2006
C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix
M Ohwada, T Wada, Y Saga, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 13, 2005
Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases
S Tsunoda, T Jobo, M Arai, et al.
European Journal of Gynaecological Oncology
|
March 23, 2006
Medroxyprogesterone acetate stimulates cdk inhibitors, p21 and p27, in endometrial carcinoma cells transfected with progesterone receptor-B cDNA
M Kawaguchi, J Watanabe, M Hamano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 11, 2010
Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)
H Nomura, D Aoki, F Takahashi, et al.
British Journal of Cancer
|
June 27, 2002
Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters
J Watanabe, H Sato, T Kanai, et al.
European Journal of Gynaecological Oncology
|
November 11, 2010
Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501)
Y Niibe, J Watanabe, S Tsunoda, et al.
Page
of 5